Recall: D-0112-2025
Class II - Potentially Harmful
Class IIClassification
2024-10-25Initiated
TerminatedStatus
Lannett Company Inc.Firm
Product
Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37
Reason
Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.
Distribution
Nationwide in the USA
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.